Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gil Shenberg"'
Autor:
Orr Green, Gil Shenberg, Roni Baruch, Lihi Argaman, Talya Levin, Ian Michelson, Ruthy Hadary, Boris Isakovich, Miri Golos, Reut Schwartz, Ronan MacLoughlin, Nimrod Adi, Nadir Arber, Shiran Shapira
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2523 (2023)
Rationale: Acute respiratory distress syndrome (ARDS) is a major global health concern with a significant unmet need. EXO-CD24 is delivered via inhalation-reduced cytokines and chemokine secretion and lung injury in ARDS and improved survival in mice
Externí odkaz:
https://doaj.org/article/279f02338c0d4c76b4e8338848d39cc4
Autor:
Shiran Shapira, Marina Ben Shimon, Mori Hay‐Levi, Gil Shenberg, Guy Choshen, Lian Bannon, Michael Tepper, Dina Kazanov, Jonathan Seni, Shahar Lev‐Ari, Michael Peer, Dimitrios Boubas, Justin Stebbing, Sotirios Tsiodras, Nadir Arber
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 9, Pp n/a-n/a (2022)
Abstract A small but significant proportion of COVID‐19 patients develop life‐threatening cytokine storm. We have developed a new anti‐inflammatory drug, EXO‐CD24, a combination of an immune checkpoint (CD24) and a delivery platform (exosomes
Externí odkaz:
https://doaj.org/article/e8cb646be73748bdab517e8146718ff6
Autor:
Ezra Bernstein, Shahar Lev-Ari, Shiran Shapira, Ari Leshno, Udi Sommer, Humaid Al-Shamsi, Meital Shaked, Ori Segal, Lior Galazan, Mori Hay-Levy, Miri Sror, Amira Harlap-Gat, Michael Peer, Menachem Moshkowitz, Ido Wolf, Eliezer Liberman, Gil Shenberg, Eyal Gur, Hanoch Elran, Gustavo Melinger, Jacob Mashiah, Ofer Isakov, Elad Zrifin, Nathan Gluck, Roy Dekel, Shlomi Kleinman, Galit Aviram, Arye Blachar, Ada Kessler, Orit Golan, Ravit Geva, Ofer Yossepowitch, Alfred I. Neugut, Nadir Arber
Publikováno v:
Journal of Clinical Oncology. 41:2503-2510
PURPOSE Cancer is the second leading cause of death globally. However, by implementing evidence-based prevention strategies, 30%-50% of cancers can be detected early with improved outcomes. At the integrated cancer prevention center (ICPC), we aimed
Autor:
Shiran Shapira, Marina Ben Shimon, Mori Hay‐Levi, Gil Shenberg, Guy Choshen, Lian Bannon, Michael Tepper, Dina Kazanov, Jonathan Seni, Shahar Lev‐Ari, Michael Peer, Dimitrios Boubas, Justin Stebbing, Sotirios Tsiodras, Nadir Arber
Publikováno v:
EMBO Molecular Medicine. 14
A small but significant proportion of COVID-19 patients develop life-threatening cytokine storm. We have developed a new anti-inflammatory drug, EXO-CD24, a combination of an immune checkpoint (CD24) and a delivery platform (exosomes). CD24 inhibits
Autor:
David, Zahler, Ilan, Merdler, Keren-Lee, Rozenfeld, Gil, Shenberg, Assi, Milwidsky, Shlomo, Berliner, Shmuel, Banai, Yaron, Arbel, Yacov, Shacham
Publikováno v:
The Israel Medical Association journal : IMAJ. 23(3)
Elevated C-reactive protein (CRP) was shown to be associated with an increased risk for new-onset atrial fibrillation (AF) in ST elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI); however, th